RBC Capital Markets adjusted its stance on Celestica (NYSE:CLS), increasing the company's price target from $140.00 to $160.00, while reiterating an Outperform rating. The decision follows a recent ...

RBC Capital Markets adjusted its price target for Amgen (NASDAQ:AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on the biotechnology firm's stock. The ...

RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...

Base Metal Prices Mixed as Trade Tensions Continue to Unnerve Market -- Market Talk 0950 GMT - Base metal prices are mixed, with LME three-month copper flat at $9,174 a metric ton and LME three-month ...

RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...

Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...

FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

RBC Capital analyst Kenneth Herbert maintained a Buy rating on Transdigm Group (TDG – Research Report) yesterday and set a price target of ...

(Reuters) -Defense and space systems maker Karman Holdings, backed by Trive Capital, said on Wednesday that it is targeting a valuation of up to $2.6 billion in its New York initial public offering as ...

Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...

The general mood among these heavyweight investors is divided, with 20% leaning bullish and 55% bearish. Among these notable ...

RBC Capital Markets also maintained a cautious view on Ford and the overall U.S. automotive sector, but still expects slightly above consensus thanks to stronger retail sales for Q4. For 2025, it ...